¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¶Çöº´ÇÐȸ Cognitive Remediation in Schizophrenia : 2023-04-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÁ¶Çöº´ÇÐȸ Cognitive Remediation in Schizophrenia : 2023-04-28
±³À°ÀÏÀÚ : 2023-04-28
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü

±³À°ÁÖÁ¦ : "Cognitive Remediation in Schizophrenia"

ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¶Çöº´ÇÐȸ

´ã´çÀÚ : ¾ÈÀ¯¼®
¿¬¶ôó : 02-552-6677

À̸ÞÀÏ : goodpsydoc@gmail.com

±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú

Âü¼®¿¹»óÀÎ : 180¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í "-»çÀüµî·Ïºñ : Æò»ýȸ¿ø ¸éÁ¦/Àü¹®ÀÇ, ±³¼ö(PHD) 50,000/Àü°øÀÇ  ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 30,000/Á¤½Å°Ç°­°ü·Ã ±Ù¹«ÀÚ, ´ëÇлý,´ëÇпø»ý 20,000

- ÇöÀåµî·Ï: Á¤È¸¿ø ¸éÁ¦ / Àü¹®ÀÇ, ±³¼ö(PhD) 60,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 40,000 / Á¤½Å°Ç°­°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 30,000"

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:30~11:00 Healing: Our path from mental illness to mental health (Thomas Insel, Former director, NIMH, USA) ÀÌÀ¯»ó(¿ëÀÎÁ¤½Åº´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:00~11:20 Cognitive remediation in SZ: Behavioural interventions Á¤¿µÃ¶/Á¤¼ºÈÆ(ÀüºÏÀÇ´ë/À»ÁöÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:20~11:40 1. Characteristics and evaluation of cognitive deficit in schizophrenia ÀÌÁß¼±(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:40~12:00 2. Social cognition deficit and training in schizophrenia ¹Ú¸íÇö(´ëµ¿º´¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:00~12:30 3. Cognitive behavioral therapy for auditory hallucination in schizophrenia ±è¼º¿Ï(Àü³²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:30~12:50 Evolving clinical management in schizophrenia with long-acting injectable antipsychotics (TBD) ±ÇÁؼö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:50~13:10 1. Recent onset schizophrenia¿¡¼­ÀÇ aripiprazole Àå±âÁö¼ÓÇü ÁÖ»çÁ¦ÀÇ È¿°ú ¿À»óÈÆ(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 13:10~13:30 2. Antipsychotic polypharmacy¿¡¼­ÀÇ Ä¡·áÀü·«¿¡ ´ëÇØ Àå±âÁö¼ÓÇü ÁÖ»çÁ¦°¡ °®´Â ÀÌÁ¡ ¹× ÀÓ»óÀû À¯¿ë¼º ¾ÈÀ¯¼®(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 14:30~15:00 Cognitive remediation in SZ: Neurobiology & Digital interventions ÀÌÇåÁ¤/À̽Âȯ(°í·ÁÀÇ´ë/ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:00~15:20 1. Detection of cognitive deficit with digital therapeutics ±èÁø¿ì(ÇÏÀÌ)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:20~15:40 2. Management of cognitive deficit with digital therapeutics ³ëÀ¯Çå(À̸ðÄÚ±×)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:40~16:00 3. Neurophysiology and cognitive remediation in schizophrenia °í¸íÁø(½Çºñ¾ÆÇコ ´ëÇ¥)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:00~16:20 Cognitive remediation in SZ: Pharmacological interventions ¾È¼®±Õ/±èÀÇÅÂ(¿¬¼¼ÀÇ´ë/¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:20~16:40 1. Antipsychotics and cognitive deficit in schizophrenia ±è¼­¿µ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:40~17:10 2. Cognitive enhancers and schizophrenia ÁÖ¼º¿ì(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 17:10~17:30 3. Medications under development for cognitive enhancement in schizophrenia ÀÌÁØÀÇ(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:00~11:20 Comorbidity and differeential diagnosis of schizophrenia ¹Ú¼±Ã¶(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:20~11:40 1. Mood disorders and psychoses (ÀÌÇöÁÖ, ¼­¿ïÀÇ´ë) ÀÌÇöÁÖ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:40~12:00 2. Addictive disorders and psychoses (ÃÖÁ¤¼®, ¼º±Õ°üÀÇ´ë) ÃÖÁ¤¼®(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:00~12:30 3. Neurological conditions and psychoses ±è¼º³â(¼­¿ïÀÇ·á¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:30~12:50 Impressions from recent long acting injectable antipsychotic trials (TBD) ÀÌÁß¼­(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:50~13:10 1. The best treatment practice of PPLATs to reduce relapse & rehospitalization ÀÌÁØÈñ(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:10~13:30 2. How to build effective long-term treatment strategy for schizophrenic paatients in LAI treatment ÁÖ¼º¿ì(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:30~15:00 Management of tardive dyskinesia in schizophrenia ÁÖ¿¬È£/¹ÚÀÏÈ£(¿ï»êÀÇ´ë/°¡Å縯°üµ¿ÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:00~15:20 1. Neurobiology and clinical characteristics of TD ¿À»óÈÆ(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:20~15:40 2. Pharmacological and nonphramacological treatment of TD Àü¸í¿í(±¹¸³Áß¾ÓÀÇ·á¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:40~16:00 3. Newer medications for treatment of TD: valbenazine, deutetrabenazine ±è¾ç½Ä(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:00~16:20 Á¤½Å°Ç°­º¹Áö¹ýÀÇ ¹®Á¦Á¡°ú °³¼±¹æÇâ È«ÁøÇ¥/ÃÖÁØÈ£(¼º±Õ°üÀÇ´ë/ÃÖÁØÈ£)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:20~16:40 1. ÀþÀº Á¤½Å°úÀÇ»çµéÀÌ º» Á¤½Å°Ç°­º¹Áö¹ý ÀÌÁ¤¼®(Àϻ꺴¿ø)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:40~17:10 2. ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸÀÇ Á¤½Å°Ç°­º¹Áö¹ý °³¼±¹æ¾È ÀÌÈ­¿µ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 04¿ù 28ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 17:10~17:30 3. Á¤½ÅÁúȯÀÚ ÀÔ¿øÁ¦µµ °³¼± ¹æ¾È ¿¬±¸ Àå¼®¿ë(¿¬¼¼´ë º¸°Ç´ëÇпø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¶Çöº´ÇÐȸ Cognitive Remediation in Schizophrenia : 2023-04-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѼҾƿµ»óÀÇÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-28
´ÙÀ½±Û Àü¶óºÏµµ ¾È°úÁöȸ ¿¬¼ö±³À°(Ä¡·á¿ë ·»Áî, ¾ç¸··»Áî, ±×¸®°í ¾ç¸·À̽Ä) : 2023-04-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 688 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 733 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,100 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,046 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 980 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,389 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,424 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷